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Marwah A. Saleh1,2, Ken Ishii1,3, Jun Yamagami1, Yuji Shirakata4, Koji Hashimoto4 and Masayuki Amagai1
Paraneoplastic pemphigus (PNP) is an autoimmune blistering disease associated with lymphoproliferative
neoplasms and characterized by antibodies against plakins and desmoglein 3 (Dsg3). Anti-Dsg3 antibodies have
a primary role in blister formation in PNP. In this study, we used phage display to clone monoclonal anti-Dsg3
antibodies from a PNP patient to further characterize their pathogenicity. We isolated 20 unique Dsg3-reactive
mAbs, which we classified into four groups according to the heavy-chain complementarity-determining region 3
(CDR3) region. Genetic analyses demonstrated that three antibody groups used the VH1-46 gene (18 clones)
and one group used the VH1-02 gene (2 clones). The results of an in vitro keratinocyte dissociation assay and a
human skin organ culture injection assay showed that three antibodies displayed pathogenic activity in blister
formation with different potencies. Epitope mapping using domain-swapped Dsg3/Dsg2 showed that these
pathogenic mAbs bound Ca2þ -dependent conformational epitopes in the middle portion of the extracellular
region of Dsg3 (EC2 and EC3 domains), in contrast to most previously characterized pathogenic pemphigus
vulgaris antibodies, which bound to the EC1 domain of Dsg3. These mAbs reflect the unique polyclonal nature
of anti-Dsg3 antibodies in PNP and represent an important tool for detailing the pathophysiological
mechanisms of blister formation in PNP.
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INTRODUCTION
Pemphigus is a group of autoantibody-mediated blistering
diseases of the skin and mucous membranes. Classic
pemphigus includes two major subtypes: pemphigus vulgaris
(PV) and pemphigus foliaceus (PF) (Stanley and Amagai,
2006). Autoimmune targets for these diseases are desmoglein
(Dsg) 3 and Dsg 1, respectively. Dsg3 and Dsg1 are members
of the cadherin family of cell–cell adhesion molecules
localized in desmosomes (Amagai et al., 1991; Stanley,
1993; Amagai, 1996).
Paraneoplastic pemphigus (PNP) is a unique subtype of
pemphigus associated with underlying neoplasms (Anhalt
et al., 1990; Mehregan et al., 1993). PNP is clinically
characterized by the presence of intractable stomatitis and
polymorphous skin eruptions. Histological findings include
suprabasal acantholysis, keratinocyte necrosis, and vacuolar
interface dermatitis (Anhalt et al., 1990). PNP patients are
known to possess characteristic autoantibodies against
several members of the plakin family (desmoplakins I and
II, BPAG1, envoplakin, periplakin, and plectin; Anhalt et al.,
1990; Oursler et al., 1992; Hashimoto et al., 1995; Kim et al.,
1997; Borradori et al., 1998; Kiyokawa et al., 1998; Mahoney
et al., 1998; Proby et al., 1999), as well as autoantibodies
against Dsg3, a common feature of PV (Joly et al., 1994). Of
these autoantibodies, those against Dsg3 are considered to
have a primary pathogenic role in blister formation in PNP
patients (Amagai et al., 1998). Plakins are located in the
cytoplasm of keratinocytes, and the circulating antibodies
cannot access them. In a previous study, the removal of anti-
Dsg3 IgG eliminated the pathogenic activity of PNP sera in
passive transfer experiments in neonatal mice, and affinity-
purified polyclonal anti-Dsg3 antibodies from PNP patient
sera induced blister formation in neonatal mice (Amagai
et al., 1998).
Epitope analysis of PNP patient sera has revealed that
Dsg3 epitopes are distributed more broadly on the extra-
cellular domains of Dsg3 than those of PV patients (Futei
et al., 2003). This suggests that the autoimmune response
against Dsg3 in PNP is more diversified than that in PV.
Phage display has been used to isolate anti-Dsg mAbs from
PV and PF patients as single-chain variable fragments (scFvs).
Pathogenic and nonpathogenic antibodies have been isolated
(Payne et al., 2005; Ishii et al., 2008; Yamagami et al., 2010).
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Characterizations of these antibodies have revealed that an
scFv form of anti-Dsg mAb can reproduce Dsg-binding
specificities. Moreover, the pathogenic scFvs in these studies
were capable of inactivating Dsgs and inducing blister
formation. In addition, genetic analysis of the isolated
antibodies revealed both heavy-chain and light-chain restric-
tion, where the heavy chain was restricted to the VH1, VH3,
and VH4 genes. The antibodies that bound to Dsg3 and/or
Dsg1 were derived from different parental B-cell clones.
In this study, to better understand the pathophysiological
mechanisms in PNP, we constructed a phage antibody library
from PNP patient samples and isolated a cohort of anti-Dsg3
mAbs in the form of scFvs. We characterized the pathogenic
activity of these isolated antibodies and characterized the
corresponding conformational epitopes on Dsg3. In addition,
we analyzed gene usage and the sequences of the variable
regions and compared them with those of anti-Dsg3
antibodies isolated from PV patients. We isolated pathogenic
anti-Dsg3 mAbs from a PNP patient. We found that the mAbs
we isolated recognized the EC2 and EC3 domains of Dsg3,
different pathogenic epitopes than those that are commonly
recognized by anti-Dsg3 mAbs from PV patients.
RESULTS
Anti-Dsg3 mAbs isolated from a PNP patient shared VH genes
with those from PV patients
We constructed a phage antibody library from peripheral
blood lymphocytes from a PNP patient. The library was
screened through multiple rounds of panning on immobilized
baculovirus-produced Dsg3 using standard panning methods.
First, we isolated 14 unique Dsg3-reactive monoclonal phage
antibodies based on heavy- and light-chain nucleotide
sequences. These clones were derived from only one
heavy-chain gene (VH1-46) and used the same light-chain
gene (2c). We then panned the library in the presence of
previously isolated clones (PNP-A1 and PNP-B1) by epitope
blocking (Ishii et al., 2008), and isolated six additional clones
encoded by VH1-46 and VH1-02 heavy-chain genes.
Pathogenic anti-Dsg3 mAbs isolated from PV patients use
the VH1-46, VH1-69, VH3-07, and VH4b genes (Payne et al.,
2005; Yamagami et al., 2010). Of the 20 isolated clones from
the PNP patient, 18 shared VH1-46. Because the H-CDR3
(heavy-chain complementarity-determining region 3) is
important for the pathogenicity of PV and PF antibodies
(Yamagami et al., 2010), we classified the 20 isolated clones
into four subgroups (A, B, C, and D) according to their H-
CDR3 sequences. Three groups (A, B, and C) were encoded
by VH1-46 and one group (D) was encoded by VH1-02.
Table 1 summarizes the genetic and immunological char-
acterization of representative clones from each group. The
nomenclature is as follows: PNP-A1¼ paraneoplastic pem-
phigus, group A, clone number 1.
Three anti-Dsg3 mAbs bound to the surfaces of human
keratinocytes
As expected, all clones bound to human Dsg3 ELISA.
Immunofluorescence analysis of normal human skin showed
that representative clones from the three groups encoding
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VH1-46 (PNP-A1, PNP-B1, and PNP-C1) were bound to the
surfaces of keratinocytes. A representative clone from the
VH1-02 group (PNP-D1) did not bind to cell surfaces
(Figure 1), although the antibody bound to recombinant
Dsg3 ELISA and was detected by immunoprecipitation/
immunoblotting (data not shown).
We tested reactivity in mice by indirect immunofluores-
cence and ELISA. Only PNP-B1 showed weak cell surface
staining of mice keratinocytes by indirect immunofluores-
cence and bound to mouse Dsg3 ELISA. None of the
antibodies bound to mouse Dsg1 ELISA (Table 1). Because
three antibodies did not crossreact to mice, we could not use
mice to test in vivo pathogenicity.
Two anti-Dsg3 mAbs bound to the EC2 domain of Dsg3 and one
mAb bound to the EC3 domain through calcium-sensitive
epitopes
As most pathogenic autoantibodies from PV and PF bind to
calcium-sensitive epitopes (Amagai et al., 1995; Payne et al.,
2005; Ishii et al., 2008), we analyzed whether the anti-Dsg3
mAbs from the PNP patient would bind calcium-sensitive
epitopes. The cell surface binding of keratinocytes by PNP-
A1, PNP-B1, and PNP-C1 was abrogated when the human
skin was preincubated with EDTA (Figure 1f). This suggests
that the clones bound to calcium-dependent conformational
epitopes.
We further characterized the Dsg3 epitopes recognized by
the isolated antibodies by immunoprecipitation/immunoblot-
ting using a series of Dsg3/Dsg2 domain-swapped molecules
produced using a baculovirus expression system (Ohyama
et al., 2012). PNP-A1 bound to the EC3 domain of Dsg3,
whereas PNP-B1 and PNP-C1 bound to the EC2 domain
(Figure 2b). We also characterized the epitopes recognized
by the polyclonal Dsg3 antibodies from the PNP patient. The
epitopes were broad, and covered EC1 to EC4 (Figure 2b).
This contrasts with classic PV patients, in whom the dominant
epitopes recognized by Dsg3 antibodies are EC1 and EC2
(Figure 2a and b).
The isolated mAbs represent only a subset of the polyclonal
anti-Dsg3 antibodies in the PNP patient
The isolated mAbs were tested for their ability to inhibit the
binding of polyclonal antibodies in the PNP patient’s serum
to human Dsg3 ELISA. Each scFv competed with the PNP
patient’s serum in the ELISA plate in serial dilutions. PNP-A1,
PNP-B1, PNP-C1, and PNP-D1 inhibited at most only 15%
(± 2.4), 11% (±3.2), 9% (±4.3), and 13% (±5.2),
respectively (Figure 2c), of the binding of the patient’s serum
to Dsg3. We further prepared a mixture of equal volumes of
the four isolated scFvs and then competed this mixture in
serial dilutions with the patient’s serum on the ELISA plate.
The mixture inhibited binding of polyclonal antibodies in the
patient’s serum by only 16% (±1.3). This suggests that the
isolated mAbs represent only a subset of the polyclonal anti-
Dsg3 antibodies in the PNP patient’s serum and that the
majority of polyclonal anti-Dsg3 antibodies may recognize
different epitopes.
Three anti-Dsg3 mAbs caused fragmentation of epidermal
sheets in an in vitro dissociation assay
To examine the pathogenicity of the mAbs, we performed an
in vitro dissociation assay using normal human epidermal
keratinocytes (Ishii et al., 2005). The normal human
epidermal keratinocytes were incubated with the antibodies
(1 mgml–1) in the presence of 0.5 mgml–1 exfoliative toxin A
(ETA), which inhibits Dsg1 (Amagai et al., 2000; Hanakawa
et al., 2004; Nishifuji et al., 2010). Gentle pipetting will result
in fragmentation of the epidermal cell sheet if the antibody is
pathogenic. AK23 (IgG form) was used as a positive control
(Figure 3). AK23 is a well-characterized mouse bivalent anti-
Dsg3 mAb that crossreacts with human Dsg3 (Tsunoda et al.,
2003). ETA alone was used as a negative control (Figure 3).
The dissociation scores for PNP-A1, PNP-B1, and PNP-C1
were 10 (±0.09), 9 (±0.9), and 32 (±10), respectively
(n¼3). We also prepared mixtures combining two scFvs
(PNP-A1þPNP-B1, PNP-B1þPNP-C1 and PNP-A1þPNP-
C1) and all the three scFvs, of which the final concentration
Figure 1. Immunological analysis of anti-desmoglein 3 (Dsg3) mAbs isolated from the paraneoplastic pemphigus (PNP) patient. Indirect immunofluorescence
of anti-Dsg3 single-chain variable fragment (scFv) clones in human skin. (a) PNP-A1, (b) PNP-B1, and (c) PNP-C1showed cell surface staining of the
keratinocytes, whereas clone (d) PNP-D1 was negative. (e) An scFv isolated from a pemphigus vulgaris (PV) patient (D31)2/28 was used as a positive control.
(f) Pretreatment of human skin cryosections with EDTA prevented the cell binding of PNP-C1 to keratinocytes. Bar¼ 100mm.
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of the total scFvs was 1 mgml–1. The dissociation scores of
PNP-A1þPNP-B1, PNP-B1þPNP-C1, and PNP-B1þPNP-
C1 were 10 (±1), 10 (±2), and 25 (±3), respectively. The
dissociation score of the mixture of the three scFvs was 30
(±6). None of the combined scFvs showed higher dissocia-
tion indexes than the single scFvs, indicating that there is no
apparent synergism among the scFvs examined in this study.
Three anti-Dsg3 mAbs caused acantholysis in organ-cultured
human skin
Two scFvs failed to crossreact with mice, and thus neonatal
mice could not be used in an in vivo assay. Thus, we assessed
pathogenicity using human skin tissues. The scFvs were
injected into the dermis of normal human skin in organ
culture. The antibodies were injected with a minimal amount
of ETA to inactivate Dsg1. An scFv isolated from a PV patient
((D31)2/28; Payne et al., 2005) was used as a positive control.
(D31)2/28 crossreacts with both Dsg3 and Dsg1, and thus
ETA is not required to inactivate Dsg1. Direct immunofluor-
escence analysis of the skin organ cultures showed binding of
PNP-A1, PNP-B1, and PNP-C1 to the surfaces of keratino-
cytes (data not shown). Hematoxylin and eosin staining
showed that PNP-C1 caused typical suprabasal acantholysis,
indicating that the antibody is pathogenic (Figure 4). PNP-C1
showed pathogenic activity in a dose-dependent manner
when 50, 100, or 150ml scFv (1 mgml–1) was injected. PNP-A1
and PNP-B1 only produced focal acantholysis when 100 or
150ml scFv (1 mgml–1) was injected. We quantitatively
evaluated acantholysis by comparing the width of the blister
with the width of the whole skin specimen, a measure we
called the organ culture acantholysis index (Figure 4). PNP-A1,
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Figure 3. Anti-desmoglein 3 (Dsg3) single-chain variable fragments (scFvs)
caused the dissociation of cultured human epidermal keratinocytes. Cultured
human keratinocytes were incubated with exfoliative toxin A (ETA) with or
without scFvs or a mixture of the scFvs at a concentration of 1mgml–1 and
then treated with dispase to release cell monolayers. Released cell sheets
were exposed to mechanical shear stress to evaluate intercellular adhesion.
The dissociation index was calculated from the number of cell sheet
fragments (N) for each treatment using the following formula:
((N with mAb–N with ETA only)/(N with AK23–N with ETA only))100.
Data are shown as the mean±SD. Top panel shows the photos of
the wells. PNP, paraneoplastic pemphigus.
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PNP-B1, and PNP-C1 scored 2.2 (±3.1), 5.4 (±0.9), and
14.1 (±0.5), respectively, when 150 ml scFv (1 mgml–1) was
injected.
The findings of the in vitro dissociation assay and organ
culture assay together suggest that PNP-A1, PNP-B1, and
PNP-C1 have the ability to induce loss of cell adhesion.
Moreover, the lower number of fragments in the dissociation
assay and the focal acantholysis in the skin organ culture
suggest that PNP-A1 and PNP-B1 are weaker than PNP-C1.
PNP-D1 caused neither fragmentation of cell sheets nor
blistering in organ culture (data not shown), which suggests
that it is not pathogenic.
DISCUSSION
Phage display has previously been used to isolate mAbs from
PV (Payne et al., 2005) and PF patients (Ishii et al., 2008;
Yamagami et al., 2010). In this study, we constructed a phage
library from a PNP patient and succeeded in isolating a
cohort of anti-Dsg3 mAbs. We proved that three anti-Dsg3
mAbs (PNP-A1, PNP-B1, and PNP-C1) possess the ability, as
scFvs, to induce blister formation in the skin. The ability of
the isolated antibodies to induce loss of cell adhesion was
weaker than that of the positive controls, as assessed by the
number of fragments in a dissociation assay and the extent of
acantholysis in an organ culture injection assay.
The differences in the abilities of the scFvs isolated from
the PNP patient in this study and previously isolated
antibodies from PV patients to induce loss of cell adhesion
may be explained by the epitopes of the antibodies. Whereas
PNP-B1 and PNP-C1 bound to the EC2 domain of Dsg3, PNP-
A1 bound to EC3. This result contrasts with the previous
finding that pathogenic mAbs from PV patients bound to the
EC1 region of Dsg3, which is predicted to form the
intercellular trans-adhesive interface (Tsunoda et al., 2003;
Payne et al., 2005). This is the region containing the
dominant epitopes in human PV. In a previous study, mouse
mAbs were isolated from PV model mice generated by
transfer of naive Dsg3/ splenocytes (Kawasaki et al., 2006).
Antibodies recognizing the middle portion of Dsg3 proved to
be weakly pathogenic. Taken together with our data, these
findings suggest that anti-Dsg IgG antibodies that recognize
the middle and C-terminal extracellular domains of Dsg3
may also contribute to blister formation. Moreover, our
findings indicate that antibodies against the EC2 and EC3
domains of Dsg3 are involved in blister formation.
It was previously reported that a combination of weakly
pathogenic anti-Dsg3 IgG autoantibodies had synergistic
pathogenic effects on blister formation (Kawasaki et al.,
2006). When the pathophysiology of PNP is considered, the
severe phenotype may be caused by the synergistic effects of
low-potency pathogenic anti-Dsg3 antibodies that recognize
various epitopes. However, the combination of the three
isolated mAbs did not show any apparent synergistic effect in
dissociation assay (Figure 3). Other anti-Dsg3 mAbs may be
required to show synergistic effect on keratinocyte dissocia-
tion. It will be interesting to study whether pathogenic
antibodies from PNP and PV patients differ in their activation
of signal transduction pathways. In addition, it may be
interesting to study whether the binding of PNP antibodies to
Dsg3 for long periods induces secondary inflammation in the
skin, a phenomenon that may be observed in PNP.
We analyzed the gene usage of the isolated Dsg3 mAbs.
Three groups of mAbs shared the VH1-46 locus, and one
group was derived from VH1-02. Some mAbs isolated from
PV patients by phage display use the same VH1-46 gene
(Payne et al., 2007; Yamagami et al., 2010). In one study
using the heterohybridoma technique, anti-Dsg3 and anti-
Dsg1 antibodies from PV patients did not use VH1-46 (Qian
et al., 2007). In another study whose aim was to clone B cells
isolated by flow cytometry from peripheral blood of PV
patients, some Dsg3-specific B cells used VH1-46 (Yamagami
et al., 2008). This suggests that Dsg3-specific B cells from
PNP and PV patients may come from restricted parental
B cells.
In conclusion, we isolated a cohort of Dsg3 mAbs from a
PNP patient, three of which had the ability to induce blister
formation. The pathogenic mAbs recognized the middle
portion of Dsg3 (the EC2 and EC3 domains), in contrast to the
pathogenic PV antibodies. These findings reflect the unique
polyclonal nature of anti-Dsg3 IgG antibodies in PNP, and
indicate key differences between PNP and PV in terms of the
pathophysiological mechanisms of blister formation and
autoimmune responses. The antibodies we have isolated will
be useful for elucidating the molecular mechanisms of blister
formation in PNP and the adhesive function of Dsgs.
MATERIALS AND METHODS
PNP patient
We used peripheral blood from a 76-year-old male patient with
active PNP to construct the PNP library (Figure 5). The patient was
diagnosed with B-cell lymphoma through microscopic examination
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Figure 4. Pathogenicity assay (injection of single-chain variable fragments
(scFvs) into organ cultured human skin). Injection of PNP-C1 (paraneoplastic
pemphigus, group C, clone number 1) with low-dose exfoliative toxin A (ETA)
caused suprabasal acantholysis. PNP-A1 and PNP-B1 caused focal
acantholysis. An scFv isolated from a pemphigus vulgaris (PV) patient (D31)2/
28 was used as a positive control. We did not add ETA to the positive control
because the positive control inhibits both desmoglein (Dsg)3 and Dsg1 (Payne
et al., 2005). Calculation of the degree of acantholysis based on the organ
culture acantholysis index (OCAI). Hematoxylin and eosin staining was
performed, and the OCAI was calculated after the injection of 150 ml of
1mg ml–1 scFv. Data are shown as the mean±SD. Bar¼50 mm.
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of a lymph node biopsy. This study was approved by the institution
review board of Keio University and was conducted according to the
Declaration of Helsinki Principles. All samples were used with
informed consent.
Construction of the phage library
Using previously described methods (Barbas, 2001), we constructed
separate IgG-k and IgG-l phage libraries from 1 107 mononuclear
cells isolated from 50ml peripheral blood collected from the PNP
patient. Reverse transcriptase–PCR was used to amplify the Ig
variable regions of the heavy (VH) and light chains (VL). The gene
fragments were then cloned into the phagemid vector pComb3X
(Scripps Institute, La Jolla, CA). The phagemid library was electro-
porated into the XL-1 Blue strain of E. coli (Stratagene, La Jolla, CA)
through superinfection by the helper phage VCSM13 (Stratagene). In
this system, filamentous phage particles express scFv antibodies
(with a C-terminal (His)6 tag and an HA tag) fused to the pIII
bacteriophage coat protein. Recombinant phages were purified from
culture supernatants by polyethylene glycol precipitation and
resuspended in phosphate-buffered saline (pH 7.4) containing 1%
BSA and 1mM CaCl2. The library comprised more than 2 108
independent transformants, as determined by titering on XL1-Blue
E. coli after transformation. To validate library diversity, we analyzed
the sequences of 11 phage clones from the unpanned library. The
results showed marked heterogeneity in VH and VL gene usage.
Panning of the phage library
ELISA plates coated with recombinant Dsg3 (MBL, Nagoya, Japan)
were used to isolate phage clones as described previously (Payne
et al., 2005). Briefly, four wells were incubated with blocking buffer
(50mM Tris (pH 7.5), 150mM NaCl, 1mM CaCl2, and 3% skim milk)
at room temperature for 1 hour. The phage library was diluted into
blocking buffer and then incubated in Dsg3-coated wells for 2 hours
at room temperature. After five washes with Tris-buffered saline/Ca
containing 0.1% Tween-20, adherent phages were eluted with
76mM citric acid (pH 2.0) and then neutralized with 2 M unbuffered
Tris. The eluted phages were amplified in XL1-Blue E. coli and
rescued by superinfection with VCSM13. Phages were harvested
from bacterial culture supernatants and then repanned four more
times. Individual phage clones were isolated at each round of
panning and then analyzed for binding to Dsg3 by ELISA using a
horseradish peroxidase–conjugated anti-M13 antibody (GE Health-
care Bio-Sciences, Uppsala, Sweden). For epitope-blocked panning,
the phage library was first mixed with the purified recombinant scFv
clones PNP-A1 and PNP-B1, and then incubated on immobilized
Dsg3 for 2 hours at room temperature.
Sequence analysis of scFv antibodies
Recombinant phagemids were purified using a plasmid preparation
system (Qiagen Sciences, Germantown, MD), and the VH and VL
inserts were sequenced using pComb3X-specific primers as de-
scribed previously (Barbas, 2001). The nucleotide sequences were
compared with germline sequences in the V Base sequence directory
(http://vbase.mrc-cpe.cam.ac.uk/) to determine their germline gene
origins and interrelatedness.
Production and purification of scFv antibodies
The Top10 F0 nonsuppressor strain of E. coli (Invitrogen, Carlsbad,
CA) was infected with an individual phage clone, and soluble scFvs
were purified from the bacterial periplasmic space using FastBreak
(Promega, Madison, WI) and TALON Metal Affinity Resin (Clontech
Laboratories, Mountain View, CA). The purity of the scFv prepara-
tion was evaluated by SDS-PAGE, followed by Coomassie staining,
which showed a single predominant band.
Dsg3 scFv ELISA
The reactivity of scFvs against human Dsg3 was measured by Dsg3
ELISA using a horseradish peroxidase–conjugated anti-HA mAb
(3F10; dilution, 1:1,000; Roche Diagnostics, Mannheim, Germany).
Direct and indirect immunofluorescence
Immunofluorescence for scFvs was performed on human skin and
neonatal mouse skin and tail. Binding was detected through staining
with rat anti-HA mAb (3F10; dilution, 1:100; Roche Diagnostics),
followed by an Alexa Flour 488-conjugated anti-rat IgG (dilution,
1:200; Invitrogen).
Dissociation assay
Normal human epidermal keratinocytes (a gift from Ehime Uni-
versity) were grown on collagen-coated 12-well microplates (Iwaki
Science Products, Tokyo, Japan) until confluent. Thereafter, 1.2mM
CaCl2 and scFvs (1 mgml
–1) were added, and the plates were
incubated for 12 hours at 37 1C. ETA (0.5mgml–1) was added and
incubated for 2 hours. The cells were washed twice with phosphate-
buffered saline (þ ), resuspended in 1ml phosphate-buffered saline
(þ ), and pipetted five times using a 1-ml pipette. The cells were
fixed by adding formaldehyde (5%). A few drops of 0.02% crystal
violet were added to stain the particles, with the plates being
incubated overnight to allow the stain to be absorbed. Three pictures
were taken and were analyzed manually. The dissociation index was
Figure 5. Clinical, histological, and immunofluorescence photographs of the
paraneoplastic pemphigus (PNP) patient from whom the phage antibody
library was constructed. (a) The patient suffered from severe mucosal and
skin erosions. (b) Hematoxylin and eosin staining of the patient’s skin biopsy
showed suprabasal blistering and vacuolar degeneration. (c) Direct
immunofluorescence (DIF) of the patient’s skin showed IgG deposition on the
surfaces of keratinocytes. (d) Indirect immunofluorescence of the patient’s
IgG-stained rat bladder transitional epithelium. Bars¼ 100mm.
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calculated from the number of fragments (N) using the following
formula: ((N with mAb–N with ETA only)/(N with AK23–N with ETA
only)) 100. For the combination of scFvs, we prepared mixtures
containing equal concentrations of two scFvs (PNP-A1þ PNP-B1,
PNP-B1þ PNP-C1, and PNP-A1þ PNP-C1) or all of the three scFvs,
whose final concentration of the total scFvs was 1 mgml–1.
Epitope mapping by immunoprecipitation/immunoblotting
To determine the epitopes of the PNP patient, as well as the scFvs,
we used the following baculovirus-produced recombinant human
Dsg3/Dsg2 domain-swapped molecules tagged with an E-tag and a
histidine tag: Dsg3-EC1 (1-101), Dsg3-EC2 (95-221), Dsg3-EC3 (212-
328), Dsg3-EC4 (320-440), and Dsg3-EC5 (440-551; Ohyama et al.,
2012). Baculovirus-infected insect cell culture supernatants contain-
ing recombinant molecules were incubated with the serum or scFvs
for 30minutes, and then immunoprecipitated with protein G
Sepharose 4 Fast Flow beads (GE Healthcare Bio-Sciences) for
serum or anti-HA agarose (Sigma-Aldrich, St Louis, MO) for scFvs (at
4 1C overnight with gentle rotation). After washing with Tris-buffered
saline/Ca, immunoprecipitates were resuspended in Laemmli sample
buffer, separated by SDS-PAGE, and transferred to polyvinylidene
difluoride membranes (Millipore, Billerica, MA). Membranes were
probed with a horseradish peroxidase–conjugated anti-E-tag anti-
body (dilution, 1:5,000; GE Healthcare Bio-Sciences). Anti E-tag
antibody (GE Healthcare Bio-Sciences) was used as positive control.
Human organ culture injection
Specimens of normal skin that were left over after skin biopsies were
obtained from our dermatology outpatient clinic. After fat removal,
the specimens were cut into pieces with a diameter of 4mm.
Intradermal injection of 100 ml purified scFv and low-dose ETA was
then performed using an insulin syringe, and the specimens were
transferred to Transwells (Corning, NY) containing MCDB medium
(a gift from Ehime University) and 1.2mM CaCl2. At 24 hours, the
skin was harvested for direct immunofluorescence and histology.
The organ culture acantholysis index was calculated as (width of
blister/total width of specimen) 100.
Inhibition ELISA
Inhibition ELISA was performed as described previously (Ishii et al.,
2008). The diluted PNP serum competed with an scFv mixture in a
Dsg3 ELISA, and was detected using horseradish peroxidase–conju-
gated anti-human IgG (MBL). The following calculation was used: %
inhibition¼ (1[(OD PNP serum with competitorsOD AM3-13)/
(OD PNP serum without competitorsOD AM3-13)]) 100, where
AM3-13 is an scFv isolated from a thrompocytopenic purpura
patient.
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